Valneva SE (VALN) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
VALN Revenue Growth
Revenue Breakdown (FY 2024)
VALN's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
VALN Revenue Analysis (2013–2024)
As of May 7, 2026, Valneva SE (VALN) generated trailing twelve-month (TTM) revenue of $179.9 million, reflecting significant decline in growth of -35.8% year-over-year. The most recent quarter (Q3 2025) recorded $29.4 million in revenue, down 39.1% sequentially.
Looking at the longer-term picture, VALN's 5-year compound annual growth rate (CAGR) stands at +6.1%, indicating steady revenue expansion. The company achieved its highest annual revenue of $361.3 million in 2022.
Revenue diversification analysis shows VALN's business is primarily driven by IXIARO (59%), Third Party Products (21%), and DUKORAL (20%). With over half of revenue concentrated in IXIARO, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including NVAX (-52.5% YoY), DYAI (-21.9% YoY), and IBRX (+1026.0% YoY), VALN has underperformed the peer group in terms of revenue growth. Compare VALN vs NVAX →
VALN Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| VALNCurrent | $180M | -35.8% | +6.1% | 7.9% | |
 NVAX | $1.1B | -52.5% | +118.8% | 50.1% | |
 DYAI | $3M | -21.9% | +15.8% | -168.8% | |
 IBRX | $15M | +1026.0% | +221.4% | -2334.2% | |
 SIGA | $95M | -31.8% | -5.4% | 25.1% | |
 PFE | $62.6B | +1.4% | +8.5% | 24.7% |
VALN Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $169.6M | +10.3% | $71.0M | 41.9% | $13.3M | 7.9% |
| 2023 | $153.7M | -57.5% | $52.8M | 34.4% | $-82,087,000 | -53.4% |
| 2022 | $361.3M | +3.8% | $36.9M | 10.2% | $-113,443,000 | -31.4% |
| 2021 | $348.1M | +215.5% | $160.2M | 46.0% | $-61,391,000 | -17.6% |
| 2020 | $110.3M | -12.6% | $56.0M | 50.8% | $-55,110,000 | -50.0% |
| 2019 | $126.2M | +11.6% | $76.2M | 60.4% | $-811,000 | -0.6% |
| 2018 | $113.0M | +7.4% | $69.6M | 61.6% | $6.3M | 5.5% |
| 2017 | $105.3M | +11.9% | $59.3M | 56.3% | $-3,954,000 | -3.8% |
| 2016 | $94.1M | +20.0% | $51.0M | 54.2% | $-42,568,000 | -45.3% |
| 2015 | $78.4M | +112.2% | $31.4M | 40.1% | $-19,934,000 | -25.4% |
See VALN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs VALN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare VALN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonVALN — Frequently Asked Questions
Quick answers to the most common questions about buying VALN stock.
Is VALN's revenue growth accelerating or slowing?
VALN revenue declined -35.8% year-over-year, contrasting with the 5-year CAGR of +6.1%. TTM revenue fell to $180M. This reverses the prior growth trend.
What is VALN's long-term revenue growth rate?
Valneva SE's 5-year revenue CAGR of +6.1% reflects the variable expansion pattern. Current YoY growth of -35.8% is below this long-term average.
How is VALN's revenue distributed by segment?
VALN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.